Transpire Bio announced today that its Chief Executive Officer, Dr. Xian-Ming Zeng, will present at the 44th Annual J.P.
Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...
AM PTSOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and ...
The Chosun Ilbo on MSN
JP Morgan Healthcare Conference Sets Bio Industry Trends
The JP Morgan Healthcare Conference, considered the world’s largest pharmaceutical and biotech investment event, will take ...
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of ...
Immorta Bio Inc., a scientific longevity company dedicated to Treating Diseases of Aging and Treating Aging as Disease(TM), today announced new data demonstrating that its combination therapy of ...
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that Nate Fernhoff, Ph.D., Orca Bio’s co-founder and ...
Presentation details: Conference: 44 th Annual J.P. Morgan Healthcare Conference Presenter: Dr. Natalia Misciattelli (CEO) Date: 15 th January 2026 Location: The Westin St. Francis Hotel, San ...
Biogen Inc. ( BIIB) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 4:30 PM EST ...
The world's largest bio investment event, the JP Morgan Healthcare Conference (JPMHC), is just a week away. With the total ...
Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback